Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Richfield EW, Jones EJ, Alty JE. Palliative care for Parkinson’s disease: a summary of the evidence and future directions. Palliat Med. 2013;27(9):805–10.
Nirenberg MJ. Dopamine agonist withdrawal syndrome: implications for patient care. Drugs Aging. 2013;30:587–92.
Newman EJ, Grosset DG, Kennedy PG. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care. 2009;10(1):136–40.
Chung SJ, Asgharnejad M, Bauer L, et al. Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective. Expert Rev Neurother. 2017;17(7):737–49.
Rotigotine. Aust Prescr. 2008;31:49–55.
Northumbria Healthcare NHS Foundation Trust Parkinson’s Disease Team PD ‘Nil by Mouth’ medication dose calculator. 2014. http://pdmedcalc.co.uk/. Accessed 16 Oct 2022.
Managing a patient with Parkinson disease who is nil-by-mouth. Melbourne: Therapeutic Guidelines Limited; 2021. https://www.tg.org.au. Accessed 16 Oct 2022.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Parker-Smith, J., Corbett, C. (2023). Medication Management in Parkinson’s Disease. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_31
Download citation
DOI: https://doi.org/10.1007/978-981-99-4440-8_31
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4439-2
Online ISBN: 978-981-99-4440-8
eBook Packages: MedicineMedicine (R0)